(HR) Healthcare Realty Trust - Ratings and Ratios
Medical Outpatient Buildings, Real Estate Management, Property Leasing
HR EPS (Earnings per Share)
HR Revenue
Description: HR Healthcare Realty Trust
Healthcare Realty Trust Incorporated (NYSE:HR) is a real estate investment trust (REIT) specializing in medical outpatient buildings, primarily situated around prominent hospital campuses. With a portfolio of approximately 650 properties spanning over 38 million square feet, the company has established itself as a leader in its niche, focusing on strategic growth through targeted acquisitions and developments.
The companys concentration in 15 growth markets positions it for potential long-term success, given the increasing demand for healthcare services. Key performance indicators (KPIs) to monitor include the companys Funds From Operations (FFO) per share, which is a critical metric for REITs, as it provides insight into their operational profitability. Additionally, the companys debt-to-equity ratio and interest coverage ratio will be essential in assessing its financial health and ability to service its debt.
From a valuation perspective, the companys Price-to-FFO ratio, a more relevant metric than P/E for REITs, can help determine if the stock is undervalued or overvalued relative to its peers. Furthermore, the dividend yield and payout ratio are crucial, as REITs are required to distribute a significant portion of their income to shareholders. A stable or growing dividend can be indicative of the companys financial stability and commitment to returning value to shareholders.
Given its specialization and market presence, Healthcare Realtys ability to maintain occupancy rates and navigate the evolving healthcare landscape will be key factors in its future performance. Monitoring the companys guidance on same-store net operating income (NOI) growth, as well as its pipeline of development projects, will provide insights into its growth prospects.
HR Stock Overview
| Market Cap in USD | 6,141m |
| Sub-Industry | Health Care REITs |
| IPO / Inception | 1993-05-26 |
HR Stock Ratings
| Growth Rating | -20.8% |
| Fundamental | 35.8% |
| Dividend Rating | 54.1% |
| Return 12m vs S&P 500 | -11.6% |
| Analyst Rating | 3.0 of 5 |
HR Dividends
| Dividend Yield 12m | 7.00% |
| Yield on Cost 5y | 7.31% |
| Annual Growth 5y | 0.66% |
| Payout Consistency | 85.7% |
| Payout Ratio | 251.5% |
HR Growth Ratios
| Growth Correlation 3m | 92.6% |
| Growth Correlation 12m | -43.8% |
| Growth Correlation 5y | -59% |
| CAGR 5y | 1.75% |
| CAGR/Max DD 5y | 0.04 |
| Sharpe Ratio 12m | -0.18 |
| Alpha | -9.88 |
| Beta | 0.949 |
| Volatility | 20.82% |
| Current Volume | 4785.3k |
| Average Volume 20d | 3003.6k |
| Stop Loss | 16.9 (-3.1%) |
| Signal | 0.83 |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-403.5m TTM) > 0 and > 6% of Revenue (6% = 72.2m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -0.21pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -11.28% (prev -28.23%; Δ 16.95pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 516.1m > Net Income -403.5m (YES >=105%, WARN >=100%) |
| Net Debt (4.67b) to EBITDA (559.4m) ratio: 8.35 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.74 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (349.6m) change vs 12m ago -6.13% (target <= -2.0% for YES) |
| Gross Margin 61.70% (prev 35.76%; Δ 25.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 10.91% (prev 11.15%; Δ -0.24pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.38 (EBITDA TTM 559.4m / Interest Expense TTM 227.4m) >= 6 (WARN >= 3) |
Altman Z'' -2.35
| (A) -0.01 = (Total Current Assets 383.7m - Total Current Liabilities 519.4m) / Total Assets 10.24b |
| (B) -0.42 = Retained Earnings (Balance) -4.31b / Total Assets 10.24b |
| (C) -0.01 = EBIT TTM -87.3m / Avg Total Assets 11.02b |
| (D) -0.79 = Book Value of Equity -4.30b / Total Liabilities 5.42b |
| Total Rating: -2.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 35.81
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield 1.69% = 0.84 |
| 3. FCF Margin 15.16% = 3.79 |
| 4. Debt/Equity 0.97 = 2.05 |
| 5. Debt/Ebitda 8.39 = -2.50 |
| 6. ROIC - WACC -6.65% = -8.32 |
| 7. RoE -7.82% = -1.30 |
| 8. Rev. Trend -66.53% = -3.33 |
| 9. Rev. CAGR -1.06% = -0.18 |
| 10. EPS Trend -29.92% = -0.75 |
| 11. EPS CAGR -93.43% = -2.50 |
What is the price of HR shares?
Over the past week, the price has changed by +1.04%, over one month by +4.27%, over three months by +24.09% and over the past year by +4.34%.
Is Healthcare Realty Trust a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HR is around 18.60 USD . This means that HR is currently overvalued and has a potential downside of 6.65%.
Is HR a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 9
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the HR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17.6 | 1.1% |
| Analysts Target Price | 17.6 | 1.1% |
| ValueRay Target Price | 20 | 14.7% |
Last update: 2025-08-29 04:39
HR Fundamental Data Overview
CCE Cash And Equivalents = 25.5m USD (last quarter)
P/E Forward = 10.8342
P/S = 5.0239
P/B = 1.2671
P/EG = 4.67
Beta = 0.736
Revenue TTM = 1.20b USD
EBIT TTM = -87.3m USD
EBITDA TTM = 559.4m USD
Long Term Debt = 4.69b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (0.0)
Debt = 4.69b USD (Calculated: Short Term 0.0 + Long Term 4.69b)
Net Debt = 4.67b USD (from netDebt column, last quarter)
Enterprise Value = 10.81b USD (6.14b + Debt 4.69b - CCE 25.5m)
Interest Coverage Ratio = -0.38 (Ebit TTM -87.3m / Interest Expense TTM 227.4m)
FCF Yield = 1.69% (FCF TTM 182.3m / Enterprise Value 10.81b)
FCF Margin = 15.16% (FCF TTM 182.3m / Revenue TTM 1.20b)
Net Margin = -33.55% (Net Income TTM -403.5m / Revenue TTM 1.20b)
Gross Margin = 61.70% ((Revenue TTM 1.20b - Cost of Revenue TTM 460.5m) / Revenue TTM)
Tobins Q-Ratio = -2.51 (set to none) (Enterprise Value 10.81b / Book Value Of Equity -4.30b)
Interest Expense / Debt = 1.12% (Interest Expense 52.5m / Debt 4.69b)
Taxrate = 21.0% (US default)
NOPAT = -87.3m (EBIT -87.3m, no tax applied on loss)
Current Ratio = 0.74 (Total Current Assets 383.7m / Total Current Liabilities 519.4m)
Debt / Equity = 0.97 (Debt 4.69b / last Quarter total Stockholder Equity 4.82b)
Debt / EBITDA = 8.39 (Net Debt 4.67b / EBITDA 559.4m)
Debt / FCF = 25.75 (Debt 4.69b / FCF TTM 182.3m)
Total Stockholder Equity = 5.16b (last 4 quarters mean)
RoA = -3.94% (Net Income -403.5m, Total Assets 10.24b )
RoE = -7.82% (Net Income TTM -403.5m / Total Stockholder Equity 5.16b)
RoCE = -0.89% (Ebit -87.3m / (Equity 5.16b + L.T.Debt 4.69b))
RoIC = -0.88% (NOPAT -87.3m / Invested Capital 9.92b)
WACC = 5.77% (E(6.14b)/V(10.83b) * Re(9.51%)) + (D(4.69b)/V(10.83b) * Rd(1.12%) * (1-Tc(0.21)))
Shares Correlation 5-Years: 0.0 | Cagr: 24.39%
Discount Rate = 9.51% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 71.32% ; FCFE base≈203.4m ; Y1≈184.4m ; Y5≈160.8m
Fair Price DCF = 6.44 (DCF Value 2.26b / Shares Outstanding 351.6m; 5y FCF grow -11.62% → 3.0% )
Revenue Correlation: -66.53 | Revenue CAGR: -1.06%
Rev Growth-of-Growth: -8.95
EPS Correlation: -29.92 | EPS CAGR: -93.43%
EPS Growth-of-Growth: 39.93
Additional Sources for HR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle